Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason S Lewis

Showing results (291-300 of 359) with videos related to

Pageof 36
Sort By:
Theranostics|January 7, 2020
Delivery of polymeric nanostars for molecular imaging and endoradiotherapy through the enhanced permeability and retention (EPR) effectJeroen A C M Goos, Andrew Cho, Lukas M Carter, et al.
Bioconjugate Chemistry|July 12, 2016
PET Imaging of Extracellular pH in Tumors with (64)Cu- and (18)F-Labeled pHLIP Peptides: A Structure-Activity Optimization StudyDustin Wayne Demoin, Linden C Wyatt, Kimberly J Edwards, et al.
ACS Chemical Biology|June 16, 2017
Antibodies Against Specific MUC16 Glycosylation Sites Inhibit Ovarian Cancer GrowthThapi Dharma Rao, Alberto Fernández-Tejada, Abram Axelrod, et al.
Genes & Development|August 17, 2014
CDK9-mediated transcription elongation is required for MYC addiction in hepatocellular carcinomaChun-Hao Huang, Amaia Lujambio, Johannes Zuber, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 26, 2021
A simple strategy to reduce the salivary gland and kidney uptake of PSMA-targeting small molecule radiopharmaceuticalsTeja Muralidhar Kalidindi, Sang-Gyu Lee, Katerina Jou, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 3, 2014
Understanding the pharmacological properties of a metabolic PET tracer in prostate cancerNerissa Therese Viola-Villegas, Sean D Carlin, Ellen Ackerstaff, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 26, 2026
Delta-like Ligand 3-Directed <sup>225</sup>Ac Radioimmunotherapy in Neuroendocrine Lung and Prostate Cancer ModelsTran T Hoang, David Bauer, Aidan Ingham, et al.
Biorxiv : the Preprint Server for Biology|April 15, 2024
Na<sub>V</sub>1.7 targeted fluorescence imaging agents for nerve identification during intraoperative proceduresJunior Gonzales, Dauren Adilbay, Paula Demetrio de Souza Franca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2018
Harnessing Androgen Receptor Pathway Activation for Targeted Alpha Particle Radioimmunotherapy of Breast CancerDaniel L J Thorek, Anson T Ku, Nicholas Mitsiades, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 13, 2021
Exploiting the MUC5AC Antigen for Noninvasive Identification of Pancreatic CancerKelly E Henry, Travis M Shaffer, Kyeara N Mack, et al.
Pageof 36

Showing results (291-300 of 359) with videos related to

Sort By:
Pageof 36
Theranostics|January 7, 2020
Delivery of polymeric nanostars for molecular imaging and endoradiotherapy through the enhanced permeability and retention (EPR) effectJeroen A C M Goos, Andrew Cho, Lukas M Carter, et al.
Bioconjugate Chemistry|July 12, 2016
PET Imaging of Extracellular pH in Tumors with (64)Cu- and (18)F-Labeled pHLIP Peptides: A Structure-Activity Optimization StudyDustin Wayne Demoin, Linden C Wyatt, Kimberly J Edwards, et al.
ACS Chemical Biology|June 16, 2017
Antibodies Against Specific MUC16 Glycosylation Sites Inhibit Ovarian Cancer GrowthThapi Dharma Rao, Alberto Fernández-Tejada, Abram Axelrod, et al.
Genes & Development|August 17, 2014
CDK9-mediated transcription elongation is required for MYC addiction in hepatocellular carcinomaChun-Hao Huang, Amaia Lujambio, Johannes Zuber, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 26, 2021
A simple strategy to reduce the salivary gland and kidney uptake of PSMA-targeting small molecule radiopharmaceuticalsTeja Muralidhar Kalidindi, Sang-Gyu Lee, Katerina Jou, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 3, 2014
Understanding the pharmacological properties of a metabolic PET tracer in prostate cancerNerissa Therese Viola-Villegas, Sean D Carlin, Ellen Ackerstaff, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 26, 2026
Delta-like Ligand 3-Directed <sup>225</sup>Ac Radioimmunotherapy in Neuroendocrine Lung and Prostate Cancer ModelsTran T Hoang, David Bauer, Aidan Ingham, et al.
Biorxiv : the Preprint Server for Biology|April 15, 2024
Na<sub>V</sub>1.7 targeted fluorescence imaging agents for nerve identification during intraoperative proceduresJunior Gonzales, Dauren Adilbay, Paula Demetrio de Souza Franca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2018
Harnessing Androgen Receptor Pathway Activation for Targeted Alpha Particle Radioimmunotherapy of Breast CancerDaniel L J Thorek, Anson T Ku, Nicholas Mitsiades, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 13, 2021
Exploiting the MUC5AC Antigen for Noninvasive Identification of Pancreatic CancerKelly E Henry, Travis M Shaffer, Kyeara N Mack, et al.
Pageof 36